AZD1705
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD1705, covering 2026-03-30 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia [Phase 1]